Seer (SEER) Receivables - Affiliates (2020 - 2021)
Seer (SEER) posted quarterly Receivables - Affiliates of $101000.0 for Q1 2021, up 2.02% quarter-over-quarter from $99000.0 in Q4 2020.
Seer (SEER) Receivables - Affiliates (2020 - 2021) Analysis & Trends
Seer's Receivables - Affiliates history runs 2 years deep, the most recent figure standing at $101000.0 for Q1 2021.
- In Q1 2021, Receivables - Affiliates changed N/A year-over-year to $101000.0; the TTM figure through Mar 2021 stood at $101000.0 (changed N/A YoY), while the FY2020 annual figure was $99000.0, changed N/A from the prior year.
- Receivables - Affiliates for Q1 2021 stood at $101000.0, up from $99000.0 in the prior quarter.
- The five-year high for Receivables - Affiliates was $101000.0 in Q1 2021, with the low at $99000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Affiliates (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 101,000.00 |
| Mar 31, 2021 | 101,000.00 |
| Dec 31, 2020 | 99,000.00 |
| Dec 31, 2020 | 99,000.00 |